SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome -- Ignore unavailable to you. Want to Upgrade?


To: Beltropolis Boy who wrote (642)12/22/1998 11:22:00 AM
From: MoneyMade  Read Replies (1) | Respond to of 900
 
LIPO---News Liposome Co. (LIPO) 9 13/16 +13/16: Hambrecht & Quist upgrades drug developer from "hold" to "buy" based on resolution of the uncertainties regarding new Abelcet competitors and launch of Evacet; expects Evacet launch in the fall of 1999, while Abelcet sales have continued to grow; raises Q4 EPS estimate from loss of $0.02 to net of $0.01 a share; has a price target in the range of $25-$30 a share.....





M$ney